Women in Psychedelics: Learning from Success

4/24/24 From AIMS Co-Director Dr. Leanna Standish:
I am pleased to be presenting at Women in Psychedelics, an extraordinary virtual gathering of medicine women, doctors, public interest entrepreneurs, researchers, therapists, authors, activists, and others on April 27 and 28, and hope you will join me. My presentation will address ayahuasca and is scheduled for 4/27 5 pm PST.
Speakers come from four continents and eight countries. Several are people of color and three are indigenous. We will discuss timely issues and showcase success stories relevant to and featuring women in psychedelics.

SAT/SUN APR 27-28, 10 AM TO 11 AM 25-HOUR CONFERENCE, 24 SPEAKERS

Women in Psychedelics: Learning from Success

 

Women in Psychedelics: Learning from Success (WiP) is an extraordinary virtual gathering of medicine women, doctors, public interest entrepreneurs, researchers, therapists, authors, activists, and others. They come from four continents, eight countries. Several are people of color, three indigenous.  
WiP will run from 10 AM, Saturday, April 27 until 11 AM, Sunday, April 28. One advantage of this approach is that people all over the world can tune into some part of our event at a convenient time. Twenty-five amazing women will make 30-minute presentations on a wide range of subjects relevant to and featuring women in psychedelics and will showcase a psychedelic success story. A moderated Q&A and discussion will follow for the rest of the hour. The last hour of the event will feature several of our speakers in a summary session. A video of the complete program will be available promptly.  
This free Zoom event is organized by Holly House, a Seattle-based effort to educate the public about the risks and benefits of psychedelics to individuals and society. The principal sponsor is Awake.net, a non-profit social impact network, offering space for the entheogenic community to be informed, collaborate, and speed transformation. Awake’s public service mission is to advance and use ibogaine to help end the addiction and overdose epidemic. Co-sponsors are the Entheo Society of Washington, supporting the therapeutic, spiritual, and medical right to use entheogens and their decriminalization, and Ancestral Heart, dedicated to the preservation and deeper understanding of ancient ritual and indigenous wisdom.
Screen Shot 2024 04 13 at 1.57.00 PM
Screen Shot 2024 04 13 at 1.58.52 PM
Screen Shot 2024 04 14 at 11.28.51 AM
GET ZOOM LINK

facebook  twitter  linkedin  youtube  instagram

Presented by Holly House. Principal Sponsor Awake.net, Co-sponsors EntheoSociety of Washington and Ancestral Heart

Awake apple logo final center

Latest Blog Posts

A Holistic Solution to Health Disparities: Naturopathic Medicine and Culturally Competent Care 

A Holistic Solution to Health Disparities: Naturopathic Medicine and Culturally Competent Care 

Healthcare Disparities in African American Communities African Americans continue to face significant disparities in healthcare. From higher mortality rates for chronic conditions like cancer and heart disease to underdiagnosis of autoimmune disorders, these inequities stem from systemic racism, implicit bias, and a lack of cultural sensitivity among providers. Studies show that Black patients are less likely to receive adequate pain management and more likely to feel unheard or dismissed during medical visits. These disparities erode trust in the healthcare system and lead to poorer outcomes and avoidable suffering. For many, navigating the system can feel isolating and disempowering, leaving them ...

Read More
At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

At AIMS Institute we prescribe low dose oral naltrexone for ‘long COVID’

A recent paper in the Frontiers in Medicine states that An underutilized intervention for long  COVID is low dose naltrexone, which has an established safety profile for a variety of conditions. ‘Naltrexone is a non-selective opioid antagonist currently approved by the US Food and Drug Administration (FDA) for the treatment of alcohol and opioid dependence and is prescribed at 50–150 mg daily. At doses below 5 mg, it is considered low-dose naltrexone (LDN), exhibits anti-inflammatory and analgesic properties, and has been used off-label to reduce severity of symptoms in conditions such as fibromyalgia, multiple sclerosis, complex regional pain syndrome, myalgic encephalomyelitis/chronic fatigue ...

Read More
Unusual Suspects

Unusual Suspects

Psychedelic Therapies Gain New Advocates Texas Law Magazine Written by Robin Berghaus. Art by Matthieu Bourel Published November 6, 2024 Marcus Capone served seven combat tours as a Navy SEAL — including missions with SEAL Team Six, the nation’s preeminent counterterrorism unit — before being medically retired in 2013. For years, he struggled to find effective treatments for his traumatic brain injuries, depression, and post-traumatic stress disorder. Capone tried antidepressants, talk therapy, hyperbaric oxygen therapy, transcranial magnetic stimulation, and he visited several brain clinics. Nothing worked. When Capone’s life began falling apart, he considered suicide. His wife was just as ...

Read More
Call Us Text Us
Skip to content